TM Capital

JULY 17, 2024

Josh has extensive experience completing transactions across key healthcare services sectors including physician practice management, ambulatory surgery centers, and pharmaceutical services. Josh holds a B.A. in Economics from Boston College, a J.D. from Tulane University, and is a member of The Florida Bar.

Capital 52

Capital Pharmaceutical Private Equity Healthcare 52

Cooley M&A

JANUARY 20, 2022

1] Major all-cash acquisitions have followed, such as Arena Pharmaceutical’s agreement to sell to Pfizer for $6.7 Midsize pharmaceutical buyers pursuing opportunistic acquisition strategies, with robust capital markets and high valuations having limited the pool of attractive assets available in recent years.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Focus Investment Banking

DECEMBER 20, 2024

Private equity-backed ophthalmology groups have seen significant growth over the last eight years, with more than 30 platforms establishing themselves in the market; most completing numerous add-on (individual practice) acquisitions. Other groups have sold within the private equity space.

Private Equity 52

Private Equity Healthcare Equities Sale 52